title: JACIE accreditation for blood and marrow transplantation: past, present and future directions of an international model for healthcare quality improvement.
abstract: Blood and marrow transplantation (BMT) is a complex and evolving medical speciality that makes substantial demands on healthcare resources. To meet a professional responsibility to both patients and public health services, the European Society for Blood and Marrow Transplantation (EBMT) initiated and developed the Joint Accreditation Committee of the International Society for Cellular Therapy and EBMT-better known by the acronym, JACIE. Since its inception, JACIE has performed over 530 voluntary accreditation inspections (62% first time; 38% reaccreditation) in 25 countries, representing 40% of transplant centres in Europe. As well as widespread professional acceptance, JACIE has become incorporated into the regulatory framework for delivery of BMT and other haematopoietic cellular therapies in several countries. In recent years, JACIE has been validated using the EBMT registry as an effective means of quality improvement with a substantial positive impact on survival outcomes. Future directions include development of Europe-wide risk-adjusted outcome benchmarking through the EBMT registry and further extension beyond Europe, including goals to faciliate access for BMT programmes in in low- and middle-income economies (LMIEs) via a 'first-step' process.
authors.affiliation: Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.|Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
authors.forename: J A
authors.initials: JA
authors.lastname: Snowden
authors.affiliation: EBMT Executive Office, Barcelona, Spain.
authors.forename: E
authors.initials: E
authors.lastname: McGrath
authors.affiliation: Servicio de Hematologia y Hemoterapia, Hospital Universitario Puerta de Hierro, Madrid, Spain.
authors.forename: R F
authors.initials: RF
authors.lastname: Duarte
authors.affiliation: Department of Hematology, Azienda Ospedaliera Universitaria Careggi, Florence, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Saccardi
authors.affiliation: Department of Haematology, Southampton General Hospital, Southampton, UK.
authors.forename: K
authors.initials: K
authors.lastname: Orchard
authors.affiliation: Klinik fuer Innere Medizin I, Medizinische Universitaet Wien, Vienna, Austria.
authors.forename: N
authors.initials: N
authors.lastname: Worel
authors.affiliation: Department of Haematology, University Medical Centre, Utrecht, The Netherlands.
authors.forename: J
authors.initials: J
authors.lastname: Kuball
authors.affiliation: Programme de Transplantation &Therapie Cellulaire, Institut Paoli Calmettes, Marseilles, France.
authors.forename: C
authors.initials: C
authors.lastname: Chabannon
authors.affiliation: Department of Hematology, Hospital Saint Antoine, Paris, France.
authors.forename: M
authors.initials: M
authors.lastname: Mohty
mesh_terms: D000068:Accreditation; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation; D005060:Europe; D005260:Female; D006801:Humans; D008297:Male; D008962:Models, Theoretical; D011787:Quality of Health Care